Aclaris Therapeutics, Inc.
2019 Q4 - 2025 Q4 (17 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 17 | 0.0% | 5,649 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 11 | 0.0% | 5,668 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 8 | 0.0% | 5,664 | 6/30/2025 |
| 2024 Q1 | 5/16/2024 | 9 | 0.0% | 6,982 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 58 | 0.0% | 55,559 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 404 | 0.0% | 59,047 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 696 | 0.0% | 67,101 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 526 | 0.0% | 65,025 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 1,045 | 0.0% | 66,324 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 1,033 | 0.0% | 65,616 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 865 | 0.0% | 61,998 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 1,051 | 0.0% | 60,986 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 966 | 0.0% | 66,460 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1,149 | 0.0% | 63,821 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 1,052 | 0.0% | 59,896 | 6/30/2021 |
| 2020 Q1 | 5/13/2020 | 49 | 0.0% | 47,336 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 88 | 0.0% | 46,787 | 12/31/2019 |